Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Rybicki

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Cancer Letters|September 13, 2005
Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesisBenjamin A Rybicki, Nora L Nock, Adnan T Savera, et al.
American Journal of Human Genetics|August 5, 2005
The BTNL2 gene and sarcoidosis susceptibility in African Americans and WhitesBenjamin A Rybicki, Jose L Walewski, Mary J Maliarik, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancerBenjamin A Rybicki, David V Conti, Andrea Moreira, et al.
BMC Genetics|February 21, 2004
Susceptibility scoring in family-based association testingLaila M Poisson, Benjamin A Rybicki, Steven W Coon, et al.
Carcinogenesis|October 16, 2012
Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African AmericansDeliang Tang, Oleksandr N Kryvenko, Yun Wang, et al.
Cancer Causes & Control : CCC|June 20, 2020
Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health dataDaniel M Frendl, Mara M Epstein, Hassan Fouayzi, et al.
BMC Genetics|February 21, 2004
Analysis of gene x environment interactions in sibships using mixed modelsJill S Barnholtz-Sloan, Laila M Poisson, Steven W Coon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2014
Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patientsAlbert M Levin, Karla J Lindquist, Andrew Avila, et al.
Cancer Causes & Control : CCC|December 11, 2012
A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancerAndrew Rundle, Kathryn M Neckerman, Daniel Sheehan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012
Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancerOleksandr N Kryvenko, Michelle Jankowski, Dhananjay A Chitale, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Cancer Letters|September 13, 2005
Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesisBenjamin A Rybicki, Nora L Nock, Adnan T Savera, et al.
American Journal of Human Genetics|August 5, 2005
The BTNL2 gene and sarcoidosis susceptibility in African Americans and WhitesBenjamin A Rybicki, Jose L Walewski, Mary J Maliarik, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancerBenjamin A Rybicki, David V Conti, Andrea Moreira, et al.
BMC Genetics|February 21, 2004
Susceptibility scoring in family-based association testingLaila M Poisson, Benjamin A Rybicki, Steven W Coon, et al.
Carcinogenesis|October 16, 2012
Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African AmericansDeliang Tang, Oleksandr N Kryvenko, Yun Wang, et al.
Cancer Causes & Control : CCC|June 20, 2020
Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health dataDaniel M Frendl, Mara M Epstein, Hassan Fouayzi, et al.
BMC Genetics|February 21, 2004
Analysis of gene x environment interactions in sibships using mixed modelsJill S Barnholtz-Sloan, Laila M Poisson, Steven W Coon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2014
Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patientsAlbert M Levin, Karla J Lindquist, Andrew Avila, et al.
Cancer Causes & Control : CCC|December 11, 2012
A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancerAndrew Rundle, Kathryn M Neckerman, Daniel Sheehan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012
Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancerOleksandr N Kryvenko, Michelle Jankowski, Dhananjay A Chitale, et al.
Pageof 14